Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34